Dementia Flashcards
(13 cards)
Mild to moderate Alzheimers first line
Mono therapy with donepezil, galantamine or rivastigimine (acetylcholinesterase inhbitors)
If CI= Memantine
Moderate to severe alzheimer treatment
Acetylcholinesterase inhibitor + memantine
Severe alzheimer disease treatment
Memantine
management of cognitive symptoms
The use of drugs that contribute to anticholinergic/antimuscaranic burden should be minimised e.g. olazapine, quetiapine, amitriptyline, paroxetine, solifenacin
Discontinuation of acetylcholinesterase inhibitors in moderate Alzheimers
Can cause significant worsening in cognitive function; treatment discontinuation should not be based on disease severity alone
mild-moderate dementia with Lewy bodies treatment
Doneprizil or rivastigimine
Only consider galantamine if both not tolerated
Severe dementia with lewy bodies treatment
Doneprizil or rivastigimine
Memantine if CI or not tolerated
FTD treatment
Both acetylcholinesterase inhibitors and memantine not recommended
Vascular dementia treatment
Acetylcholinesterase inhibitors [unlicensed indication] or memantine hydrochloride [unlicensed indication] should only be considered in patients with vascular dementia if they have suspected co-morbid Alzheimer’s disease, Parkinson’s disease dementia, or dementia with Lewy bodies.
When should antipsychotics be used in dementia
Only when they are at risk of harming themselves/others or are experiencing agitation/hallucinations or delusions that are causing them severe distress
MHRA: INCREASE RISK OF STROKE/DEATH when antipsychotics are used in elderly patients with dementia
Galantamine side effects
Serious skin reactions
Chest pain
Dizziness/fainting
SOB
Shakiness of limbs
Irregular/slow Heart Beat
Management of depression and anxiety in dementia
If mild dementia and mild depression/anxiety -> offer CBT, Multisensory stimulation relaxation or animal assisted therapies
Antidepressants should be reserved for pre-existing mental health issues
Management of sleep disturbances in dementia
Non drug approaches to manage including sleep hygiene, exposure to daylight and increasing exercise and activity